Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Sarcopenia is believed to be associated with disability and metabolic complications. The objective of this study was to examine the metabolic and quality-of-life profile of sarcopenic overweight and obese postmenopausal women. In this cross-sectional study of 136 healthy overweight and obese postmenopausal women, 9 class I sarcopenic women were identified. Class I sarcopenia was defined as an appendicular lean body mass index (ALBMI) ≤ 6.44 kg·m–2 (appendicular lean body mass/height). Outcome measures were body composition (dual energy X-ray absorptiometry and computed tomography), blood lipids, inflammation markers, blood pressure, insulin sensitivity (homeostasis model assessment and hyperinsulinemic-euglycemic clamp), cardiorespiratory fitness, and quality of life (Medical Outcomes Study General Health Survey questionnaire). By design, class I sarcopenic women (n = 9) had a significantly lower ALBMI and appendicular lean body mass than nonsarcopenic women (n = 127). In addition, class I sarcopenic women tended to have lower levels of insulin resistance (p = 0.070) and fasting glucose (p = 0.054). However, no difference between the groups was observed for quality of life. This study showed that, in our sample of class I sarcopenic overweight and obese postmenopausal women, subjects did not present an unfavourable metabolic or quality-of-life profile, compared with nonsarcopenic overweight and obese postmenopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sarcopenic obesity (as defined by low appendicular lean mass normalized for height2 and increased BMI) was associated with unfavourable scores on the Medical Outcomes Survey234.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [234]
In the citing paper
“Moreover, several cross-sectional studies have reported that older adults with sarcopenic obesity [based on DXA-measured ALM/weight (%) and % body fat or BMI] did not have a significantly higher prevalence of CVD than adults without sarcopenia or obesity (34, 95–97).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [96]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“Moreover, homeostasis model assessment was calculated, as proposed by Matthews et al. (1985), using 3 basal values of fasting serum glucose and insulin (ðfasting insulin fasting glucoseÞ=22:5), where fasting insulin is measured as mU mL–1, and fasting glucose is measured as mmol L–1).”
MethodGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Measuring Health: A Guide to Rating Scales and Questionnaires
McDowell, I., & Newell, C. (1987) · Cited by 4,207
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 7×
“Moreover, sarcopenia may affect quality of life and lead to functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002).”
BackgroundMethodInfluentialJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 5×
“Moreover, sarcopenia may affect quality of life and lead to functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002).”
BackgroundInfluentialStewart, A. L. (1989) · JAMA · doi:10.1001/jama.262.7.907 · Cited by 2,085
Stewart, A. L. (1989) · JAMA · doi:10.1001/jama.1989.03430070055030 · Cited by 1,735 · cited 2×
“…using a validated selfadministered questionnaire (Medical Outcomes Study General Health Survey), which evaluated quality-of-life subscales for physical functioning, pain, social functioning, role functioning, mental health, and health perceptions (Stewart et al. 1989; McDowell and Newell 1996).”
MethodLau, D. C. W., Douketis, J. D., Morrison, K. M., Hramiak, I. M., Sharma, A. M., Ur, E., & Panel, F. M. O. T. O. C. C. P. G. E. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061409 · Cited by 1,154 · cited 2×
“However, our results indicate that class I sarcopenic women did not display an unfavourable metabolic profile; it was comparable to that of nonsarcopenic women in most of the measured parameters, despite a higher percentage of fat mass, a well known correlate of adverse metabolic outcomes (Lau et al. 2007).”
ResultGoodpaster, B. H., Leland Thaete, F., Simoneau, J.-A., & Kelley, D. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1579 · Cited by 1,012 · cited 1×
“Second, it could be related to reduced muscle lipid infiltration, which has been associated with higher insulin sensitivity (Goodpaster et al. 1997).”
BackgroundMorley, J. E., Baumgartner, R. N., Roubenoff, R., Mayer, J., & Nair, K. S. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.113504 · Cited by 936 · cited 2×
“…that the loss of skeletal muscle mass observed with advancing age is associated with functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002), while others have reported that fat mass is an important risk marker for disability (Visser…”
BackgroundGoodpaster, B. H., Krishnaswami, S., Resnick, H., Kelley, D. E., Haggerty, C., Harris, T. B., Schwartz, A. V., Kritchevsky, S., & Newman, A. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.372 · Cited by 619 · cited 2×
“, insulin resistance and dyslipidemia) that may lead to an increased risk for cardiovascular disease and (or) type 2 diabetes (Goodpaster et al. 2003; von Eyben et al. 2003).”
BackgroundThe metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579
Self-citationGlucose transporter protein content and glucose transport capacity in rat skeletal muscles
Henriksen, E. J., Bourey, R. E., Rodnick, K. J., Koranyi, L., Permutt, M. A., & Holloszy, J. O. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.4.e593 · Cited by 434 · cited 1×
“First, it could be related to a preferential preservation of type I muscle fibers, since type IIb fibers have been shown to have higher levels of insulin resistance (James et al. 1985; Henriksen et al. 1990; Kern et al. 1990).”
BackgroundWeight gain in breast cancer survivors: prevalence, pattern and health consequences
Vance, V., Mourtzakis, M., McCargar, L., & Hanning, R. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00805.x · Cited by 409
Visser, M., Langlois, J., Guralnik, J. M., Cauley, J. A., Kronmal, R. A., Robbins, J., Williamson, J. D., & Harris, T. B. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.3.584 · Cited by 328
Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats
James, D. E., Jenkins, A. B., & Kraegen, E. W. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.5.e567 · Cited by 321 · cited 1×
“First, it could be related to a preferential preservation of type I muscle fibers, since type IIb fibers have been shown to have higher levels of insulin resistance (James et al. 1985; Henriksen et al. 1990; Kern et al. 1990).”
BackgroundSternfeld, B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf023 · Cited by 311 · cited 2×
“…is associated with functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002), while others have reported that fat mass is an important risk marker for disability (Visser et al. 1998a, 1998b; Sternfeld et al. 2002; Lebrun et al. 2006).”
BackgroundInsulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level
Kern, M., Wells, J. A., Stephens, J. M., Elton, C. W., Friedman, J. E., Tapscott, E. B., Pekala, P. H., & Dohm, G. L. (1990) · Biochemical Journal · doi:10.1042/bj2700397 · Cited by 267
Visser, M., Harris, T. B., Langlois, J., Hannan, M. T., Roubenoff, R., Felson, D. T., Wilson, P. W. F., & Kiel, D. P. (1998) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/53a.3.m214 · Cited by 259 · cited 3×
“…is associated with functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002), while others have reported that fat mass is an important risk marker for disability (Visser et al. 1998a, 1998b; Sternfeld et al. 2002; Lebrun et al. 2006).”
BackgroundRisk due to inactivity in physically capable older adults.
Simonsick, E. M., Lafferty, M. E., Phillips, C. L., Mendes de Leon, C. F., Kasl, S. V., Seeman, T. E., Fillenbaum, G., Hebert, P., & Lemke, J. H. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.10.1443 · Cited by 242 · cited 2×
“1998a), and (or) reduced physical activity, since it has been shown that inactivity and functional impairment are strongly associated (Simonsick et al. 1993).”
BackgroundTrémollieres, F. A., Pouilles, J.-M., & Ribot, C. A. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70111-4 · Cited by 242 · cited 2×
“2002) and central fat mass (Tremollieres et al. 1996), and a decrease in lean body mass (Douchi et al.”
BackgroundThe Significance of Sarcopenia in Old Age
Dutta, C., & Hadley, E. C. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.1 · Cited by 225 · cited 3×
“…excessive adipose tissue on health status are well established, a variety of studies have reported an association of age-related changes in muscle quality, mass, and strength, with metabolic and (or) physiologic and functional impairments leading to morbidity and disability (Dutta and Hadley 1995).”
BackgroundInfluentialOrigins and Clinical Relevance of Sarcopenia
Roubenoff, R. (2001) · Canadian Journal of Applied Physiology · doi:10.1139/h01-006 · Cited by 219 · cited 3×
“Accordingly, several studies have reported that the loss of skeletal muscle mass observed with advancing age is associated with functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002), while others have reported that fat mass is an important risk marker…”
BackgroundMetabolic and Behavioral Characteristics of Metabolically Obese but Normal-Weight Women
Conus, F., Allison, D. B., Rabasa-Lhoret, R., St-Onge, M., St-Pierre, D. H., Tremblay-Lebeau, A., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0265 · Cited by 215 · cited 1×
“The cut-off values were obtained from a previous study, consisting of 128 women between 18 and 36 years (Conus et al. 2004).”
MethodSelf-citationNyholm, B., Qu, Z., Kaal, A., Pedersen, S. B., Gravholt, C. H., Andersen, J. L., Saltin, B., & Schmitz, O. (1997) · Diabetes · doi:10.2337/diab.46.11.1822 · Cited by 180
Intra-abdominal obesity and metabolic risk factors: a study of young adults
von Eyben, F. E., Mouritsen, E., Holm, J., Montvilas, P., Dimcevski, G., Suciu, G., Helleberg, I., Kristensen, L., & von Eyben, R. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802309 · Cited by 159 · cited 1×
“…that visceral adipose tissue is a fat depot that has been shown to be associated with several metabolic complications (i.e., insulin resistance and dyslipidemia) that may lead to an increased risk for cardiovascular disease and (or) type 2 diabetes (Goodpaster et al. 2003; von Eyben et al. 2003).”
BackgroundEffect of Sarcopenia on Cardiovascular Disease Risk Factors in Obese Postmenopausal Women
Aubertin‐Leheudre, M., Lord, C., Goulet, É. D. B., Khalil, A., & Dionne, I. J. (2006) · Obesity · doi:10.1038/oby.2006.267 · Cited by 151 · cited 3×
“In a similar population to ours, Aubertin-Leheudre et al. (2006) reported that class I sarcopenic obese women had lower levels of abdominal fat mass and visceral fat and a more favourable blood lipid profile than age- and fatmass-matched obese women.”
ResultMetabolically healthy but obese individuals: relationship with hepatic enzymes
Messier, V., Karelis, A. D., Robillard, M.-È., Bellefeuille, P., Brochu, M., Lavoie, J.-M., & RABASA-LHORET, R. P. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.020 · Cited by 138
Self-citationRelative contribution of aging and menopause to changes in lean and fat mass in segmental regions
Douchi, T., Yamamoto, S., Yoshimitsu, N., Andoh, T., Matsuo, T., & Nagata, Y. (2002) · Maturitas · doi:10.1016/s0378-5122(02)00161-5 · Cited by 127 · cited 2×
“Menopause is associated with body composition changes, such as an increase in total fat mass (Douchi et al. 2002) and central fat mass (Tremollieres et al.”
BackgroundLebrun, C. E. I., van der Schouw, Y. T., de Jong, F. H., Grobbee, D. E., & Lamberts, S. W. (2006) · Menopause · doi:10.1097/01.gme.0000222331.23478.ec · Cited by 112 · cited 2×
“…is associated with functional impairments and disability (Baumgartner et al. 1998; Morley et al. 2001; Roubenoff 2001; Janssen et al. 2002), while others have reported that fat mass is an important risk marker for disability (Visser et al. 1998a, 1998b; Sternfeld et al. 2002; Lebrun et al. 2006).”
BackgroundApolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women
Faraj, M., Messier, L., Bastard, J., Tardif, A., Godbout, A., Prud’homme, D., & RABASA-LHORET, R. P. R. (2006) · Diabetologia · doi:10.1007/s00125-006-0259-7 · Cited by 92 · cited 1×
“Body weight (BW), lean body mass, and fat mass were measured using dual energy X-ray absorptiometry, version 6.10.019 (General Electric Lunar Corporation, Madison, Wis.), and BMI was calculated as BW/height, in kg m–2 (Karelis et al. 2005; Faraj et al. 2006).”
MethodSelf-citationThe effect of menopause on regional and total body lean mass
Douchi, T., Yamamoto, S., Nakamura, S., Ijuin, T., Oki, T., Maruta, K., & Nagata, Y. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00035-8 · Cited by 76 · cited 1×
“Menopause is associated with body composition changes, such as an increase in total fat mass (Douchi et al. 2002) and central fat mass (Tremollieres et al. 1996), and a decrease in lean body mass (Douchi et al. 1998, 2002).”
BackgroundEffects of fat mass and body fat distribution on resting metabolic rate in the elderly
Lührmann, P. M., Herbert, B. M., & user-Berthold, M. N. A. (2001) · Metabolism · doi:10.1053/meta.2001.24871 · Cited by 75 · cited 1×
“Muscle is recognized as a metabolically active tissue, as muscle mass is a predictor of the metabolic rate (Armellini et al. 2000; Luhrmann et al. 2001).”
BackgroundAogoi, G. D. S. P. M. I. (2005) · Climacteric · doi:10.1080/13697130500196866 · Cited by 48
Nyholm, B., Qu, Z., Kaal, A., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.11.1822 · Cited by 44
Kuczmarski, M. F., Weddle, D. O., & Jones, E. M. (2010) · Journal of Nutrition for the Elderly · doi:10.1080/01639366.2010.499093 · Cited by 24
Goulet, E. D. B., Lord, C., Chaput, J.-P., Aubertin-Leheudre, M., Brochu, M., & Dionne, I. J. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-005 · Cited by 20 · cited 1×
“Moreover, another study reported that there was no difference in insulin sensitivity in class I sarcopenic, class II sarcopenic, and nonsarcopenic postmenopausal women (Goulet et al. 2007).”
BackgroundSelf-citationRisk factors for high blood pressure in women attending menopause clinics in Italy
(2005) · Maturitas · doi:10.1016/j.maturitas.2005.03.002 · Cited by 16
Armellini, F., Zamboni, M. M., Pergola, G. D., Bissoli, L., Turcato, E., GIORGINO, R., & Bosello, O. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00686.x · Cited by 9 · cited 1×
“Muscle is recognized as a metabolically active tissue, as muscle mass is a predictor of the metabolic rate (Armellini et al. 2000; Luhrmann et al. 2001).”
Background
Research works printed but not linked: 5
- Bastard, J.P., and Rabasa-Lhoret, R. 2005. Mesurer l’insulino-résistance. In Traité de diabétologie. Edited by A. Grimaldi. Médecine-Sciences Flammarion, Paris, France. pp. 90–96.
- DeFronzo R.A., 1979, Am. J. Physiol., 237, E214
- 10.2337/diabetes.46.10.1579 · DOI · Paper page
- Henriksen E.J., 1990, Am. J. Physiol., 259, E593
- James D.E., 1985, Am. J. Physiol., 248, E567
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589
Weight gain in breast cancer survivors: prevalence, pattern and health consequences
Vance, V., Mourtzakis, M., McCargar, L., & Hanning, R. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00805.x · Cited by 409
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404
Menopause and sarcopenia: A potential role for sex hormones
Messier, V., Rabasa-Lhoret, R., Barbat-Artigas, S., Elisha, B., Karelis, A. D., & Aubertin-Leheudre, M. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.01.014 · Cited by 397
“[13] observed that insulin resistance and fasting glucose tended to be lower in obese sarcopenic women compared to obese nonsarcopenicwomen.”
BackgroundResultSelf-citation
Metadata
- Authors
- Messier, V., Karelis, A. D., Lavoie, M.-E., Brochu, M., Faraj, M., Strychar, I., & Rabasa-Lhoret, R.
- Affiliations
- Université de Sherbrooke (CA)
- Département de Nutrition, Université de Montréal, 2405, chemin Cote Ste-Catherine, Montreal, QC H3T 1A8, Canada.
- Venue
- Applied Physiology, Nutrition, and Metabolism
- Publisher
- Canadian Science Publishing
- Published
- 2009-02
- Volume
- 34
- Issue
- 1
- Pages
- 18-24
- ISSN
- 1715-5312 (ISSN-L)
- 1715-5320
- OpenAlex
- W2046236289
- Cited by
- 54
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 6
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
- Locations
- Applied Physiology Nutrition and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Ottawa
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- sarcopenia, postmenopausal women, obesity, overweight, metabolic profile, quality of life, insulin resistance, body composition, cardiorespiratory fitness, serum lipids, inflammatory markers, fasting blood glucose
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Cross-Sectional Studies, Female, Humans, Insulin, Insulin Resistance, Lipids, Middle Aged, Muscular Atrophy, Obesity, Physical Fitness, Quality of Life, Surveys and Questionnaires, Body Mass Index, Postmenopause, Inflammation Mediators, Overweight, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.